En
Da
Fr
De
Sv
Deal History
About us
The Company
Team
Offices
Globalscope
Newsletter
Services
Corporate Finance
Debt Advisory
Equity Research
Growth Equity Financing
IPO Strategy & Preparation
Industries
Business Services
Consumer & Internet
Industrial Technology
Life Science
Software & TMT
Energy & Infrastructure
Research
Equity Research
Macro and Markets
Career
Events
Insights
News
Company News
Deal News
In the Media
Contact
Newsletter
En
Da
Fr
De
Sv
Main menu button
Worldwide
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Team
Deals
Contact
Worldwide
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Team
Deals
Contact
News
All
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Enrad
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
GIAB
H&D Wireless
Hanza
Herantis Pharma
InCoax
Kancera
Medclair Invest
Midsummer
Mindark PE
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Svenska Aerogel
Thinc Jetty
Viva Wine Group
Ytrade Group
Zazz Energy
Zinzino
All
Company News
Deal News
Equity Research
Events
In the Media
Insights
Macro and Markets
30 Jan 2024
Carlsquare Consumer Conference 2024
Events
28 Mar 2024
Carlsquare OMR24 After-Event
Events
28 Mar 2024
Carlsquare advised MBG energy GmbH on its sale of a 75% stake to SPIE
Deal News
27 Mar 2024
Carlsquare weekly market letter: Commodities on the move again
Equity Research
Carlsquare
25 Mar 2024
Carlsquare advised SCANVIEW on its sale to CERTEGO
Deal News
20 Mar 2024
Carlsquare weekly market letter: Inflation on the verge of a comeback
Equity Research
Carlsquare
15 Mar 2024
Equity Research Svenska Aerogel, Q4 2023: Increased sales of Quartzene™ and lower than expected costs
Equity Research
Svenska Aerogel
13 Mar 2024
Research update Biosergen: Rights issue to fund crucial step for lead project
Equity Research
Biosergen
13 Mar 2024
Carlsquare weekly market letter: The IPO window is open again
Equity Research
Carlsquare
11 Mar 2024
Equity Research InCoax, Q4 2023: Strong order intake over two quarters
Equity Research
InCoax
08 Mar 2024
First Impression InCoax, Q4 2023: Good sales and very strong order intake
Equity Research
InCoax
07 Mar 2024
Carlsquare Equity Research interview with Biosergen
Equity Research
Biosergen
06 Mar 2024
Carlsquare weekly market letter: The bitcoin rally and why it matters to all of us…
Equity Research
Carlsquare
05 Mar 2024
Equity research Zinzino: February sales above our expectations
Equity Research
Zinzino
05 Mar 2024
Carlsquare advised IK Partners on its investment in Schwingshandl
Deal News
01 Mar 2024
Human Capital Management: AI & Changing Work Landscape Set to Drive Robust Sector Growth
Insights
28 Feb 2024
Equity Research Mindark PE, Q4 2023: Adjusted accounting principles contribute to high net revenues
Equity Research
Mindark PE
28 Feb 2024
Equity research Zinzino, Q4 2023: Dividend signals sustained higher margins
Equity Research
Zinzino
28 Feb 2024
Equity Research Enrad, Q4 2023: New orders may pick up later in 2024
Equity Research
Enrad
28 Feb 2024
Equity research Candles Scandinavia Q3 2023/2024: Better momentum could trigger rerating
Equity Research
Candles Scandinavia
28 Feb 2024
Carlsquare weekly market letter: Weight loss, defence and emerging markets in focus as market seeks next leg up
Equity Research
Carlsquare
1
2
3
…
76